- Home
- FLOC vs NVCR Comparison
FLOC vs NVCR Comparison
Compare FLOC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLOC
- NVCR
- Stock Information
- Founded
- FLOC 1996
- NVCR 2000
- Country
- FLOC United States
- NVCR Switzerland
- Employees
- FLOC N/A
- NVCR N/A
- Industry
- FLOC Metal Fabrications
- NVCR Medical/Dental Instruments
- Sector
- FLOC Industrials
- NVCR Health Care
- Exchange
- FLOC Nasdaq
- NVCR Nasdaq
- Market Cap
- FLOC 1.9B
- NVCR 1.9B
- IPO Year
- FLOC 2025
- NVCR 2015
- Fundamental
- Price
- FLOC $17.18
- NVCR $19.11
- Analyst Decision
- FLOC Strong Buy
- NVCR Buy
- Analyst Count
- FLOC 5
- NVCR 6
- Target Price
- FLOC $33.40
- NVCR $32.83
- AVG Volume (30 Days)
- FLOC 440.1K
- NVCR 941.3K
- Earning Date
- FLOC 05-13-2025
- NVCR 07-24-2025
- Dividend Yield
- FLOC 0.46%
- NVCR N/A
- EPS Growth
- FLOC N/A
- NVCR N/A
- EPS
- FLOC 2.69
- NVCR N/A
- Revenue
- FLOC $660,916,000.00
- NVCR $621,711,000.00
- Revenue This Year
- FLOC $54.81
- NVCR $5.56
- Revenue Next Year
- FLOC $12.05
- NVCR $9.15
- P/E Ratio
- FLOC $6.39
- NVCR N/A
- Revenue Growth
- FLOC 156.58
- NVCR 18.27
- 52 Week Low
- FLOC $16.63
- NVCR $14.17
- 52 Week High
- FLOC $30.50
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- FLOC N/A
- NVCR 58.46
- Support Level
- FLOC N/A
- NVCR $18.66
- Resistance Level
- FLOC N/A
- NVCR $20.06
- Average True Range (ATR)
- FLOC 0.00
- NVCR 0.86
- MACD
- FLOC 0.00
- NVCR 0.19
- Stochastic Oscillator
- FLOC 0.00
- NVCR 71.98
About FLOC Flowco Holdings Inc. Class A Common Stock
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.